why choose us

First received: March 30, 2023

Clinical Trial: FAME II-10-year Follow-Up

Study Status: Completed

Recruit Status: RECRUITING

Condition: Coronary Artery Disease

Study Type: OBSERVATIONAL


Official Title: Fractional Flow Reserve-guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease - FAME II, a 10-

Brief Summary: The FAME-II trial was a prospective, multicenter, multinational, multi-continental, randomized clinical trial with an 'all comers' design.The overall purpose of the FAME-II trial was to compare the clinical outcomes, safety and cost-effectiveness of FFR-guided PCI plus optimal medical treatment (OMT) versus OMT alone in patients with stable coronary artery disease and in whom both PCI and medical treatment can be considered on the basis of the presently existing scientific evidence.FAME-II was conducted…

Read more